Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis — Stella

Recruiting

Back to Cardiac Sarcoidosis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Henri Mondor Hospital, Créteil

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~180 participants

Started

March 2025

Primary completion

March 2030

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov